Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone.

Garimella, Tushar; Wang, Reena; Luo, Wen-Lin; Wastall, Philip; Kandoussi, Hamza; Demicco, Michael; Bruce, Douglas; Hwang, Carey; Bertz, Richard; Bifano, Marc

Garimella, Tushar; Wang, Reena; Luo, Wen-Lin; Wastall, Philip; Kandoussi, Hamza; Demicco, Michael; Bruce, Douglas; Hwang, Carey; Bertz, Richard; Bifano, Marc.

Afiliación

Garimella T; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Wang R; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Luo WL; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Wastall P; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Kandoussi H; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Demicco M; Research & Development, Anaheim Clinical Trials, Anaheim, CA, USA.
Bruce D; Clinical Investigation, Yale University, New Haven, CT, USA.
Hwang C; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Bertz R; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.
Bifano M; Research & Development, Bristol-Myers Squibb, Princeton, NJ, USA.

J Int AIDS Soc ; 17(4 Suppl 3): 19628, 2014.

Article en En | MEDLINE | ID: mdl-25394132

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google